InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-20.7%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Discover the detailed record of transactions filed by Pahl, Prof. Dr. Andreas, Management Board. Insider active across 1 company, notably Heidelberg Pharma AG. Aggregated, 1 reports have been recorded. Activity tracked since 23 July 2025. The latest transaction was disclosed on 23 July 2025 (Other). Regulator: BaFin. The full history is openly available.
Declarations1 total
90,000 shares@ €1.8950.0% of flowShareBAFIN:40005738
1 of 1 declaration
About Pahl, Prof. Dr. Andreas
Prof. Dr. Andreas Pahl is a member of the Management Board at Heidelberg Pharma AG. He brings valuable expertise in the field of pharmaceutical research and development. His role involves overseeing strategic operations and guiding the scientific direction of the company.
